Developing selective small-molecule modulators of

The National Institutes of Health (NIH) is seeking a contractor to conduct a pharmacokinetic (PK) study of the compound NCGC00592266 in mice. The study will include collection of plasma, brain, liver, and pancreas samples at various time points after administration. The contractor will provide analytical results and PK data in an Excel report. The project aims to better understand the biology and therapeutic potential of PIP4Kgamma. • The contractor will conduct a PK study of NCGC00592266 in mice. • The study will include collection of plasma, brain, liver, and pancreas samples at various time points. • The contractor will provide analytical results and PK data in an Excel report. • The project aims to better understand the biology and therapeutic potential of PIP4Kgamma.